Alnylam Pharmaceuticals (ALNY.MX) Q1 2019 Earnings

7FebConfirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-48.26
-41.13
-34
-26.87

Details

Expected EPS
-43.93828
Actual EPS
-39.926524
Surprise EPS
4.01
Surprise Percent
+9.13%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -39.926524 per share for Q1 2019.

0 Comments

Share your thoughts